HIT Consultant April 17, 2024
Syed Hamza Sohail

What You Should Know:

– When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger.

Isospec Analytics has raised $1.9M to commercialize new technologies for molecular analysis that rapidly identify unknown molecules in minutes, helping pharmaceuticals, nutrition and agritech companies develop safer products and enabling researchers to discover new biomarkers.

Isospec: Redefining Molecular Analysis for Breakthroughs in Biotech

Founderful (formerly Wingman Ventures) leads Isospec’s $1.9M pre-seed round, joined by specialized investors Tiny.vc, another.vc, and Venture Kick.

Founded in 2022 by Ahmed Ben Faleh, Stephan Warnke, and Thomas Rizzo,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Investments, Technology, Trends
Banner Health, Cleveland Clinic invest millions in analytics startup: 7 notes
Morgan Health Commits $25M to Merative to Enhance Employer Data Capabilities
Senior care centers should use data analytics to prioritize patient-centered care | Viewpoint
How Predictive Analytics Reduces Hospital Readmissions
Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Share This Article